Pieris Pharmaceuticals Inc.

(PIRS) Trade

By |

Profile

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.

Contact Information

Website: www.pieris.com
Main Phone: +1 857 246-8998
Address: 255 State Street
Address 2: 9th floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02109

Issuer Information

Exchange: NSC
CEO: Stephen S. Yoder
Employees: 68
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 5.83 $ 0.14 (2.46%)
Last Price 5.83 Change $ 0.14 Change % 2.46 Tick N/A
Bid 4.80 Bid Size 200.00 Ask 5.91 Ask Size 1,400.00
Open 5.68 High 5.91 Low 5.65 Prev Close 5.69
Last Trade Volume 437,504 52 Wk Hi 9.75 52 Wk Low 4.42
Market Cap 314.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 53,980,359.00 EPS (TTM) -0.38 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 5
Number of Buys 1 5
Number of Sells 0 0
Net Activity 10000 535000
Last 10 Buys Shares
James A. Geraghty 1,000
Allan Reine 1,000
James A. Geraghty 1,000
Allan Reine 1,000
Louis Matis 1,000
Darlene M. Deptula-Hicks 1,000
Louis Matis 1,000
Stephen S. Yoder 1,000
Chau Q. Khuong 1,000
Chau Q. Khuong 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 13 13 13 13
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 11.25 11.25 11.25 11.25
Standard Deviation 2.22 2.22 2.22 2.22
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1